Correction: A MT-TL1 variant identified by whole exome sequencing in an individual with intellectual disability, epilepsy, and spastic tetraparesis

Correction to: European Journal of Human Genetics https://doi.org/10.1038/s41431-021-00900-2, published online 1 June 2021

In the original publication of the article, consortium author lists were missing in the article. The details are as below.

Solve-RD SNV-indel working group: Enzo Cohen¹³, Isabel Cuesta¹⁴, Daniel Danis¹⁵, Anne-Sophie Denommé-Pichon^16,17,18, Yannis Duffourd^16,18, Christian Gilissen^2,19, Mridul Johari²⁰, Steven Laurie³, Shuang Li²¹, Leslie Matalonga³, Isabelle Nelson¹³, Sophia Peters²², Ida Paramonov³, Sivakumar Prasanth²³, Peter Robinson¹⁵, Karolis Sablauskas^2,19, Marco Savarese²⁰, Wouter Steyaert^2,19, Ana Töpf²⁴, Joeri K. van der Velde²¹, Antonio Vitobello¹⁶

¹³Sorbonne Université, INSERM UMRS_974, Center of Research in Myology, Paris, France;

¹⁴Instituto de Salud Carlos III, Madrid, Spain;

¹⁵Jackson Laboratory for Genomic Medicine, Farmington, CT, USA;

¹⁶Inserm - University of Burgundy-Franche Comté, UMR1231 GAD, Dijon, France;

¹⁷Dijon University Hospital, Genetics Department, Dijon, France;

¹⁸Dijon University Hospital, FHU-TRANSLAD, Dijon, France;

¹⁹Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands;

²⁰Folkhälsan Research Center, University of Helsinki, Helsinki, Finland;

²¹Department of Genetics, Genomics Coordination Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;

²²Institute of Human Genetics, University of Bonn, Bonn, Germany;

²³MRC Centre for Neuromuscular Diseases and National Hospital for Neurology and Neurosurgery, UCL Queen Square Institute of Neurology, London, UK;

²⁴John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK

Solve-RD-DITF-ITHACA: Siddharth Banka^25,26, Elisa Benetti²⁷, Giorgio Casari^28,29, Andrea Ciolfi³⁰, Jill Clayton-Smith^25,26, Bruno Dallapiccola³⁰, Elke de Boer^2,31, Anne-Sophie Denommé-Pichon^16,17,18, Kornelia Ellwanger^32,33, Laurence Faivre^16,34, Christian Gilissen^2,19, Holm Graessner^32,33, Tobias B. Haack³², Anna Hammarsjö³⁵, Marketa Havlovicova³⁷, Alexander Hoischen^2,19,37, Anne Hugon³⁸, Adam Jackson²⁶, Tjitske Kleefstra^2,31, Anna Lindstrand³⁵, Estrella López-Martín³⁹, Milan Macek Jr.³⁶, Leslie Matalonga³, Manuela Morleo²⁹, Vicenzo Nigro²⁹, Ann Nordgren³⁵, Maria Pettersson³⁵, Michele Pinelli²⁹, Simone Pizzi³⁰, Manuel Posada³⁹, Francesca Clementina Radio⁴⁰, Alessandra Renieri^27,41,42, Caroline Rooryck⁴³, Lukas Ryba³⁶, Martin Schwarz³⁶, Marco Tartaglia³⁰, Christel Thauvin^16,34, Annalaura Torella^28,29, Aurélien Trimouille^10,11, Alain Verloes^38,44, Lisenka Vissers^2,31, Antonio Vitobello¹⁶, Pavel Votypka³⁶, Klea Vyshka^38,44, Birte Zurek^32,33

²⁵Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University Hospitals NHS Foundation Trust, Health Innovation Manchester, Manchester, UK;

²⁶Manchester Centre for Genomic Medicine, Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK;

²⁷Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy;

²⁸Dipartimento di Medicina di Precisione, Università degli Studi della Campania “Luigi Vanvitelli,”, Napoli, Italy;

²⁹Telethon Institute of Genetics and Medicine, Pozzuoli, Italy;

³⁰Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome, Italy;

³¹Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands;

³²Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany;

³³Centre for Rare Diseases, University of Tübingen, Tübingen, Germany;

³⁴Dijon University Hospital, Genetics Department and Centres of Reference for Development disorders and intellectual disabilities, FHU TRANSLAD and GIMI Institute, Dijon, France;

³⁵Karolinska Institutet, Solna, Sweden;

³⁶Department of Biology and Medical Genetics, Charles University Prague-2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic;

³⁷Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI), Radboud University Medical Center, Nijmegen, The Netherlands;

³⁸Department of Genetics, Assistance Publique-Hôpitaux de Paris - Université de Paris, Robert DEBRE University Hospital, 48 bd SERURIER, Paris, France;

³⁹Institute of Rare Diseases Research, Spanish Undiagnosed Rare Diseases Cases Program (SpainUDP) & Undiagnosed Diseases Network International (UDNI), Instituto de Salud Carlos III, Madrid, Spain;

⁴⁰Ospedale Pediatrico Bambino Gesù, Rome, Italy;

⁴¹Medical Genetics, University of Siena, Siena, Italy;

⁴²Genetica Medica, Azienda Ospedaliero-Universitaria Senese, Siena, Italy;

⁴³University Bordeaux, MRGM INSERM U1211, CHU de Bordeaux, Service de Génétique Médicale, Bordeaux, France;

⁴⁴INSERM UMR 1141 “NeuroDiderot”, Hôpital R DEBRE, Paris, France